MRNA insider sale by Hoge Stephen
Insider sale by company president; potential near-term downside signal, though may reflect diversification/plan rather than negative view of fundamentals.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Insider sale by company president; potential near-term downside signal, though may reflect diversification/plan rather than negative view of fundamentals.
What happened, with direct paths to the underlying reporting
MRNA President Hoge Stephen sold 53,336 shares for a total value of $3,605,514 at $67.60 per share.
Insider: Hoge Stephen
Role: officer: President
Transaction: S-Sale
Shares: 53,336
Price: $67.6
Value: $3,605,514
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.